Cystic fibrosis (CF) is most commonly caused by deletion of a single amino acid (ΔF508) in the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This mutation causes protein misfolding and disrupts many cellular functions. Many models of CFTRΔF508 misfolding exist, but none are amenable to rapid genetic dissection of the pathways that are disrupted by the mutation. He et al. now report a fluorescence-based C. elegans model that will enable such studies. They show that expressing the ΔF508 mutation in P-glycoprotein-3 (PGP-3), which is similar to mammalian CFTR, disrupts protein folding and prevents CFTR trafficking to the apical membrane of epithelial cells; this resembles the effects of the CFTRΔF508 mutation, and is rescued by the same treatments as in mammalian cells. This model will enable unbiased genetic screens for modulators of CFTR misfolding and hopefully uncover new therapeutic targets. Page 930
IN THIS ISSUE| 01 November 2012
In vivo model for modulators of CFTRΔF508 misfolding
Online Issn: 1754-8411
Print Issn: 1754-8403
Written by editorial staff. © 2012. Published by The Company of Biologists Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms.
Dis Model Mech (2012) 5 (6): 707.
- Views Icon Views
Article Versions Icon
- Version of Record 01 November 2012
- Share Icon Share
- Search Site
In vivo model for modulators of CFTRΔF508 misfolding. Dis Model Mech 1 November 2012; 5 (6): 707. doi:
Download citation file: